These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Oltipraz: a laboratory and clinical review. Benson AB J Cell Biochem Suppl; 1993; 17F():278-91. PubMed ID: 8412206 [TBL] [Abstract][Full Text] [Related]
4. Cancer chemoprotection by oltipraz: experimental and clinical considerations. Helzlsouer KJ; Kensler TW Prev Med; 1993 Sep; 22(5):783-95. PubMed ID: 8234218 [TBL] [Abstract][Full Text] [Related]
5. Oltipraz chemoprevention trial in Qidong, People's Republic of China: modulation of serum aflatoxin albumin adduct biomarkers. Kensler TW; He X; Otieno M; Egner PA; Jacobson LP; Chen B; Wang JS; Zhu YR; Zhang BC; Wang JB; Wu Y; Zhang QN; Qian GS; Kuang SY; Fang X; Li YF; Yu LY; Prochaska HJ; Davidson NE; Gordon GB; Gorman MB; Zarba A; Enger C; Muñoz A; Helzlsouer KJ Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):127-34. PubMed ID: 9488587 [TBL] [Abstract][Full Text] [Related]
6. Chronic daily low dose of 4-methyl-5-(2-pyrazinyl)-1,2-dithiole-3-thione (Oltipraz) in patients with previously resected colon polyps and first degree female relatives of breast cancer patients. Benson AB; Olopade OI; Ratain MJ; Rademaker A; Mobarhan S; Stucky-Marshall L; French S; Dolan ME Clin Cancer Res; 2000 Oct; 6(10):3870-7. PubMed ID: 11051232 [TBL] [Abstract][Full Text] [Related]
7. Chemoprotection by organosulfur inducers of phase 2 enzymes: dithiolethiones and dithiins. Kensler TW; Curphey TJ; Maxiutenko Y; Roebuck BD Drug Metabol Drug Interact; 2000; 17(1-4):3-22. PubMed ID: 11201301 [TBL] [Abstract][Full Text] [Related]
8. Role of phase 2 enzyme induction in chemoprotection by dithiolethiones. Kwak MK; Egner PA; Dolan PM; Ramos-Gomez M; Groopman JD; Itoh K; Yamamoto M; Kensler TW Mutat Res; 2001 Sep; 480-481():305-15. PubMed ID: 11506823 [TBL] [Abstract][Full Text] [Related]
9. Oltipraz chemoprevention trial in Qidong, Jiangsu Province, People's Republic of China. Zhang BC; Zhu YR; Wang JB; Wu Y; Zhang QN; Qian GS; Kuang SY; Li YF; Fang X; Yu LY; De Flora S; Jacobson LP; Zarba A; Egner PA; He X; Wang JS; Chen B; Enger CL; Davidson NE; Gordon GB; Gorman MB; Prochaska HJ; Groopman JD; Muñoz A; Kensler TW J Cell Biochem Suppl; 1997; 28-29():166-73. PubMed ID: 9589363 [TBL] [Abstract][Full Text] [Related]
10. Protective alterations in phase 1 and 2 metabolism of aflatoxin B1 by oltipraz in residents of Qidong, People's Republic of China. Wang JS; Shen X; He X; Zhu YR; Zhang BC; Wang JB; Qian GS; Kuang SY; Zarba A; Egner PA; Jacobson LP; Muñoz A; Helzlsouer KJ; Groopman JD; Kensler TW J Natl Cancer Inst; 1999 Feb; 91(4):347-54. PubMed ID: 10050868 [TBL] [Abstract][Full Text] [Related]
11. Cellular kinetics of induction by oltipraz and its keto derivative of detoxication enzymes in human colon adenocarcinoma cells. O'Dwyer PJ; Clayton M; Halbherr T; Myers CB; Yao Ks Clin Cancer Res; 1997 May; 3(5):783-91. PubMed ID: 9815750 [TBL] [Abstract][Full Text] [Related]
12. Chemoprevention by inducers of carcinogen detoxication enzymes. Kensler TW Environ Health Perspect; 1997 Jun; 105 Suppl 4(Suppl 4):965-70. PubMed ID: 9255588 [TBL] [Abstract][Full Text] [Related]
13. Chemopreventive activity of oltipraz. Clapper ML Pharmacol Ther; 1998 Apr; 78(1):17-27. PubMed ID: 9593327 [TBL] [Abstract][Full Text] [Related]
14. Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones. Kensler TW; Egner PA; Dolan PM; Groopman JD; Roebuck BD Cancer Res; 1987 Aug; 47(16):4271-7. PubMed ID: 2886217 [TBL] [Abstract][Full Text] [Related]